Cephalon Plans To File Patent Suit Vs Sandoz Over Provigil ANDA
Cephalon Inc. said in a regulatory filing to the U.S. Securities and Trade Commission that it plans to sue Sandoz Inc. over its Abbreviated New Drug Application (ANDA) for a generic...To view the full article, register now.
Already a subscriber? Click here to view full article